L-alpha-PC:Chol:DOPE-N-DBCO(69:30:1molar ratio)-Neutral Fluoroliposome DiR-DBCO

L-alpha-PC:Chol:DOPE-N-DBCO(69:30:1molar ratio)-Neutral Fluoroliposome DiR-DBCO can be used in vaccine delivery systems, where they encapsulate antigens and help in inducing immune responses.
The liposomes can encapsulate therapeutic agents, improving their solubility, stability, and bioavailability. The lipid composition supports effective delivery through biological barriers.The incorporation of fluorophores like DiR allows for non-invasive imaging in vivo. This is beneficial for studying the pharmacokinetics of liposomal formulations and their targeting to specific tissues or tumors.The bioorthogonal chemistry enabled by N-DBCO allows for precise functionalization of the liposomes with targeting ligands (e.g., antibodies, peptides) that can bind to specific cell types or disease markers. This enhances the efficacy and reduces the side effects of therapeutic agents.

msds of l-alpha-pc-chol-dope-n-dbco-69-30-1molar-ratio-neutral-fluoroliposome-dir-dbco